Comparison results
| Results: Differences General | ✘Sebocystomatosis | ✘Sebaceous gland adenoma | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 79% | ||||
| a lot of medicines | 38% | — | ||||
| benign neoplasms | — | 67% | ||||
| carcinoid | 36% | — | ||||
| benign epithelial tumors | — | 66% | ||||
| basal | 36% | — | ||||
| seborrhea | — | 61% | ||||
| anomalies of the development of the auricle | 36% | — | ||||
| tumors of the sebaceous glands | 40% | 100% | ||||
| scrotal cancer | 29% | — | ||||
| lot of moles | — | 51% | ||||
| skin cysts | 29% | — | ||||
| sebaceous gland adenoma | — | 34% | ||||
| lymphosarcoma | 29% | — | ||||
| consequences of injuries | — | 31% | ||||
| neoplasms of the vulva | 28% | — | ||||
| illness from stress | — | 30% | ||||
| tumors of the scrotum | 28% | — | ||||
| scarring | — | 29% | ||||
| dermoid | 28% | — | ||||
| swelling | — | 29% | ||||
| lot of operations in small things | 39% | 10% | ||||
| trauma | — | 28% | ||||
| there's a lot lying around | 25% | — | ||||
| skin overgrowth | — | 26% | ||||
| malignization | 25% | — | ||||
| papules | — | 21% | ||||
| primary-multiple tumors | 25% | — | ||||
| warts | — | 20% | ||||
| anomalies of teeth | 24% | — | ||||
| round rashes | — | 20% | ||||
| big head | 23% | — | ||||
| oily skin | 20% | 38% | ||||
| skin problems | 36% | 11% | ||||
| pink face | — | 17% | ||||
| genital neoplasms | 22% | — | ||||
| keratoacanthoma of the skin | — | 17% | ||||
| head tumor | 21% | — | ||||
| gastroduodenitis in children | — | 17% | ||||
| hearing impaired | 20% | — | ||||
| rashes on his legs | — | 17% | ||||
| gradual deterioration of the condition | 19% | — | ||||
| enteritis in children | — | 17% | ||||
| epithelioma | 36% | 18% | ||||
| the surface is smooth | — | 17% | ||||
| history of surgery | 33% | 17% | ||||
| nevus of the sebaceous glands | — | 17% | ||||
| skin cancer | 22% | 11% | ||||
| gastritis in children | — | 16% | ||||
| fighting | 19% | 9% | ||||
| tuberous sclerosis | — | 15% | ||||
| does not tolerate pain | 19% | 10% | ||||
| colitis in children | — | 15% | ||||
| inflammation | 15% | 8% | ||||
| yellow skin color | — | 15% | ||||
| electrocoagulation | 24% | 17% | ||||
| face is yellow | — | 15% | ||||
| cysts | 41% | 36% | ||||
| chronic enteritis | — | 14% | ||||
| uterine fibroids | — | 13% | ||||
| the rashes are pink | — | 13% | ||||
| family history of cancer | — | 13% | ||||
| crusts on the head | — | 13% | ||||
| acute colitis | — | 13% | ||||
| oncology | 35% | 47% | ||||
| gastroduodenitis | — | 12% | ||||
| acute duodenitis | — | 12% | ||||
| dermatitis and eczema | — | 12% | ||||
| erosive gastritis | — | 12% | ||||
| eczema | — | 12% | ||||
| enteritis | — | 12% | ||||
| duodenitis | — | 12% | ||||
| low body temperature | — | 11% | ||||
| warts | — | 11% | ||||
| small rash | — | 11% | ||||
| rapid growth | — | 11% | ||||
| colitis | — | 11% | ||||
| gastritis | — | 11% | ||||
| oncology relatives | — | 11% | ||||
| jaundice | — | 11% | ||||
| dermatitis | — | 10% | ||||
| oncology in the anamnesis | — | 10% | ||||
| heredity predisposition | — | 10% | ||||
| painful swelling | — | 10% | ||||
| dry | — | 9% | ||||
| hormonal disorders | — | 9% | ||||
| necrosis | — | 9% | ||||
| lowered | — | 8% | ||||
| gastrointestinal problems | — | 8% | ||||
| increased | — | 8% | ||||
Instructions
Video
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.